RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-170X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer ; volume:28 ; number:10 ; day:12 ; month:9 ; year:2022 ; pages:2162-2170 ; date:10.2022
Nature medicine ; 28, Heft 10 (12.9.2022), 2162-2170, 10.2022
- Creator
-
Elez, Elena
Ros, Javier
Fernández, Jose
Villacampa, Guillermo
Moreno-Cárdenas, Ana Belén
Arenillas, Carlota
Bernatowicz, Kinga
Comas, Raquel
Li, Shanshan
Kodack, David Philip
Fasani, Roberta
Garcia, Ariadna
Gonzalo-Ruiz, Javier
Piris-Gimenez, Alejandro
Nuciforo, Paolo
Kerr, Grainne
Intini, Rossana
Montagna, Aldo
Germani, Marco Maria
Randon, Giovanni
Vivancos, Ana
Smits, Ron
Graus, Diana
Perez-Lopez, Raquel
Cremolini, Chiara
Lonardi, Sara
Pietrantonio, Filippo
Dienstmann, Rodrigo
Tabernero, Josep
Toledo, Rodrigo A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41591-022-01976-z
- URN
-
urn:nbn:de:101:1-2022122921133383250691
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elez, Elena
- Ros, Javier
- Fernández, Jose
- Villacampa, Guillermo
- Moreno-Cárdenas, Ana Belén
- Arenillas, Carlota
- Bernatowicz, Kinga
- Comas, Raquel
- Li, Shanshan
- Kodack, David Philip
- Fasani, Roberta
- Garcia, Ariadna
- Gonzalo-Ruiz, Javier
- Piris-Gimenez, Alejandro
- Nuciforo, Paolo
- Kerr, Grainne
- Intini, Rossana
- Montagna, Aldo
- Germani, Marco Maria
- Randon, Giovanni
- Vivancos, Ana
- Smits, Ron
- Graus, Diana
- Perez-Lopez, Raquel
- Cremolini, Chiara
- Lonardi, Sara
- Pietrantonio, Filippo
- Dienstmann, Rodrigo
- Tabernero, Josep
- Toledo, Rodrigo A.
- SpringerLink (Online service)
Other Objects (12)
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Crystal structure of (2-hydroxy-3-methyl-benzoato-k 1 O- triphenyltin (IV)), C 26 H 22 O 3 Sn
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
Novel combination therapies for BRAF-mutant melanoma
Total Factor Energy Efficiency of Yangtze River Delta Region in China
The crystal structure of (4-hydroxybenzenesulfonate)-k 1 O- 6,6′-((1 E, 1′ E)- (ethane-1,2-diylbis (azaneylylidene)) bis (methaneylylidene)) bis (2-methoxyphenol)-κ 2 N, N, μ 2 O,O, κ 2 O, O)-(methanol)-cobalt (II) sodium (I), C 25 H 27 CoN 2 NaO 9 S
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Crystal structure of (2-hydroxy-3-methyl-benzoato-k 1 O- triphenyltin (IV)), C 26 H 22 O 3 Sn
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
Novel combination therapies for BRAF-mutant melanoma
Total Factor Energy Efficiency of Yangtze River Delta Region in China
The crystal structure of (4-hydroxybenzenesulfonate)-k 1 O- 6,6′-((1 E, 1′ E)- (ethane-1,2-diylbis (azaneylylidene)) bis (methaneylylidene)) bis (2-methoxyphenol)-κ 2 N, N, μ 2 O,O, κ 2 O, O)-(methanol)-cobalt (II) sodium (I), C 25 H 27 CoN 2 NaO 9 S
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Crystal structure of (2-hydroxy-3-methyl-benzoato-k 1 O- triphenyltin (IV)), C 26 H 22 O 3 Sn
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
BRAF and MEK Inhibitor Treatment for Metastatic Undifferentiated Sarcoma of the Spermatic Cord with BRAF V600E Mutation
Loss of Phd2 cooperates with BRAF V600E to drive melanomagenesis
Novel combination therapies for BRAF-mutant melanoma
Total Factor Energy Efficiency of Yangtze River Delta Region in China
The crystal structure of (4-hydroxybenzenesulfonate)-k 1 O- 6,6′-((1 E, 1′ E)- (ethane-1,2-diylbis (azaneylylidene)) bis (methaneylylidene)) bis (2-methoxyphenol)-κ 2 N, N, μ 2 O,O, κ 2 O, O)-(methanol)-cobalt (II) sodium (I), C 25 H 27 CoN 2 NaO 9 S